View drug registration information details.


ItemsRegistration information
ID599
No599
Brand NameROTARIX
IngredientsLIVE ATTENUATED HUMAN ROTAVIRUS RIX4414 STRAIN NOT LESS THAN 10 6.0 CCID 50
Dosage FormORAL SUSPENSION
Primary PackagingTUBE
Storage+2'C TO +8'C
Shelf Life36 MONTHS
Pack SizeBOX OF 1 TUBE ( 1 DOSE (1.5 ML))
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassVACCINES, ANTISERA & IMMUNOLOGICALS
IndicationsFOR THE ACTIVE IMMUNISATION OF INFANTS AGED 6-24 WEEKS FOR PREVENTION OF GASTRO-ENTERITIS DUE TO ROTAVIRUS INFECTION
ContraindicationsROTARIC SHOULD NOT BE ADMISTERED TO SUBJECTS WITH KNOW HYPERSENSITIVITY AFTER PREVIOUS ADMINISTRATION OF ROTARIX VACCIN.
Side EffectsTHE SAFETY PROFILE PRESENTED BELOW IS BASED ON DATA FROM CLINICAL TRIALS CONDUCTED WITH EITHER THE LYOPHILISED OR THE LIQUID FOR MULATION OF ROTARIX.
Unit Price-
EDL No
DescriptionCLEAR AND COLOURLESS LIQUID
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerGLAXOSMITHKLINE BIOLOGICALS S. A
CountryBELGIUM
Import Registration NoEU/1/05/330/005-011
Import Registration Date1.9.2008
ActivityCERTIFICATE RELEASED
Applied Date2024-02-23
FDD Registration No02 I 3839/13
FDD Registration Date2024-04-08
Expiry Date2027-04-07

Back to drug list